81MO Osimertinib as neoadjuvant therapy in patients with EGFR mutated resectable stage II-IIIB lung adenocarcinoma (NEOS): Updated results
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.